-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Akari Therapeutics (NASDAQ:AKTX) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 3.3 % AKTX opened at $0.87 on Friday. Akari Therapeutics has a twelve month low of $0.86 and a twelve month […]
StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a research note released on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Akari Therapeutics Stock Down 3.3 % AKTX opened at $0.87 on Friday. Akari Therapeutics has a twelve month low of $0.86 and a twelve month […]
